EngagINg the COmmunity to Reduce Preterm Birth Via Adherence To an Individualized Prematurity Prevention Plan
NCT04933812 is an interventional trial sponsored by Duke University. As of 21 Nov 2026, it is completed. It studies Preterm Birth. The registry lists an enrollment of 31 participants at 1 site in 1 country. The registry lists a start date of 21 Jun 2021 and a primary completion date of 14 Oct 2022.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04933812 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Duke University |
| Enrollment | 31 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Preterm Birth |
| Start | 21 Jun 2021 |
| Primary completion | 14 Oct 2022 |
| Study completion | 14 Oct 2022 |
| Last update posted | 4 Nov 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Sarahn Wheeler, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Duke University
Durham
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04933812
Each answer restates registry values shown on this page.
What is NCT04933812?
NCT04933812 is an interventional trial sponsored by Duke University. It studies Preterm Birth.
Who leads NCT04933812?
The registry names Sarahn Wheeler, MD (principal investigator, Duke University) as the overall official.
Where does NCT04933812 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT04933812 end?
The registry lists a primary completion date of 14 Oct 2022 and a study completion date of 14 Oct 2022. The sponsor last updated the record on 4 Nov 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.